Pheno- and genotyping of Staphylococcus epidermidis isolated from bovine milk and human skin

Veterinary Microbiology
B-M ThorbergMarie-Louise Danielsson-Tham

Abstract

The purpose of this study was to improve our knowledge concerning the epidemiology and strain diversity of Staphylococcus epidermidis isolated from bovine milk in commercial dairy herds. A total of 341 S. epidermidis isolates obtained from cows' milk (317), farmers (17) and patients (7) were characterized. Of these 105 isolates were from cows' milk in two farms, where also 17 isolates were sampled from farmers. The remaining 212 isolates from cows' milk were from 170 farms. All isolates were examined by antimicrobial susceptibility, whereas 202 were examined by pulsed-field gel electrophoresis (PFGE) and 122 by ribotyping. PFGE showed single patterns in the human strains with one exception; one strain was categorised as the same clone as four of the milk strains. PFGE divided 73 of the milk strains into 62 different patterns. The PFGE method had high discriminatory power and shows that many different S. epidermidis types exist in milk samples. Antibiotic resistance patterns matched the SmaI profiles closely in the two herds, but poorly in the routinely collected milk samples. Isolates from herd 1 showed one to five patterns, depending on the typing method used. Isolates from the milker's skin showed one pattern, which was ident...Continue Reading

References

Apr 15, 1992·FEMS Microbiology Letters·B LinaJ Fleurette
Dec 1, 1992·Epidemiology and Infection·M A DeightonR Borland
Jan 1, 1991·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·A L BrownS Tabaqchali
Jul 1, 1989·Journal of Clinical Pathology·M A Gaston, P R Hunter
Jan 1, 1985·The Journal of Applied Bacteriology·L A DevrieseG O Adegoke
Jan 1, 1980·Annual Review of Microbiology·W E Kloos
Sep 1, 1995·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·K JungR Möllby
Nov 1, 1995·Letters in Applied Microbiology·J E MatosB E Langlois
Jan 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·O LyytikäinenJ Vuopio-Varkila
Feb 9, 2000·Veterinary Microbiology·H D LarsenN E Jensen
Mar 14, 2001·Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health·B M Thorberg, B Brändström
Feb 18, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E CarrettoS Brisse

❮ Previous
Next ❯

Citations

Mar 7, 2014·The Journal of Dairy Research·Ricardo BexigaCristina L Vilela
Oct 5, 2011·Journal of Mammary Gland Biology and Neoplasia·Ruth N ZadoksYnte H Schukken
Oct 11, 2011·Journal of Mammary Gland Biology and Neoplasia·Mark A Holmes, Ruth N Zadoks
Aug 22, 2009·Foodborne Pathogens and Disease·Marin Pavlic, Mansel W Griffiths
Sep 15, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Leónides FernándezJuan M Rodríguez
Apr 17, 2012·Veterinary Microbiology·T MørkT Tollersrud
Jul 16, 2015·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K M OsmanA Arafa
Dec 4, 2014·The Veterinary Journal·Wannes VanderhaeghenSarne De Vliegher
May 23, 2016·Journal of Dairy Science·Heidi HiitiöSuvi Taponen
Sep 19, 2009·Journal of Dairy Science·B-M ThorbergK Persson Waller
Jul 18, 2018·Polish Journal of Microbiology·Rocío A Ruiz-RomeroEstela T Méndez-Olvera
Apr 29, 2019·Tropical Animal Health and Production·Jean Baptiste NdahetuyeRenée Båge

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.